Intuitive Surgical
Preço: 411.06Empresa e modelo de negócios
Intuitive Surgical is a leader in robotic-assisted surgical systems, primarily known for its da Vinci Surgical System. The company develops and markets advanced surgical technologies, including instruments and accessories that enhance minimally invasive surgery. Its core revenue sources stem from system sales, instrument and accessory sales, and service agreements. The company operates mainly in the healthcare sector, focusing on improving surgical outcomes and patient recovery times.
Perfil de investimento
Intuitive Surgical's stock is more aligned with growth investors due to its focus on innovation and expanding market presence in robotic surgery. The absence of dividends and the current volatility suggest a higher risk profile, making it less suitable for conservative investors. The company is positioned for potential long-term growth, appealing to those willing to accept higher risk for future returns.
Métricas fundamentais (experimental)
- EPS (TTM) — lucro por ação dos últimos 12 meses, $
- 8.37 OK
- Receita QoQ — crescimento da receita trimestre contra trimestre
- -3.3% ↓
- Surpresa de EPS
- 17.9% melhor que o esperado
- Volatilidade 20d
- 2.5% estável
Impacto da previsão
negativoAcompanhar no portfólio
Gráfico de preço
| Data | Antes | Depois | Motivo |
|---|---|---|---|
| 2026-05-24 02:42 | Manter | Vender | Weak momentum and fundamentals suggest caution. |
| 2026-05-16 02:32 | Vender | Manter | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-05-08 14:59 | — | Vender | Weak momentum and fundamentals raise significant risk concerns. |
| Data | Analista | Action | Alvo | Preço na época |
|---|---|---|---|---|
| 2026-06-02 12:24 | Piper Sandler | Atualizar | — → 580 | 397.60999 |
| 2026-05-27 11:27 | Goldman Sachs | Preço-alvo reduzido | 621 → 558 | 436.64 |
| 2026-04-23 10:18 | Barclays | Preço-alvo reduzido | 712 → 651 | 483.62 |
Nada ainda